MetaCap

Achieve Life Sciences Inc. Company Profile

NASDAQ: QUITHealth CareBiotechnology: In Vitro & In Vivo Diagnostic SubstancesUSD

5.56-0.31 (-5.28%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Achieve Life Sciences at a glance

Achieve Life Sciences Inc. (NASDAQ: QUIT) is a Biotechnology: In Vitro & In Vivo Diagnostic Substances company in the Health Care sector headquartered in Bothell, WA. Achieve Life Sciences is led by Dr. Andrew D. Goldberg M.D. and employs about 28 people. At a market capitalization of $573.2 million, it is considered a small-cap company.

Its SEC Central Index Key (CIK) is 0000949858, which identifies the company's filings on EDGAR.

Summary generated from market data by MetaCap's automated system. Methodology

What does Achieve Life Sciences do?

Achieve Life Sciences, Inc., a late-stage pharmaceutical company, develops and commercializes cytisinicline for nicotine independence in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a naturally occurring alkaloid that interacts with nicotine receptors in the brain that reduces the severity of nicotine withdrawal symptoms. It has license and supply agreements with Sopharma AD and University of Bristol. Achieve Life Sciences, Inc., is headquartered in Bothell, Washington.

Business description based on the company's public filings.

Company information

Legal name
Achieve Life Sciences Inc.
Ticker
NASDAQ: QUIT
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
CEO
Dr. Andrew D. Goldberg M.D.
Employees
28
Headquarters
22722 29th Dr. SE, Bothell, WA, United States
Phone
604 210 2217
Market cap
$573.25M
SEC CIK
0000949858
Latest annual report
10-K/A · Apr 30, 2026

Companies similar to Achieve Life Sciences

QUIT peer companies
CompanyPrice% ChgMarket capCompare
QDELQuidelOrtho Corporation8.32-6.73%$570.86Mvs QUIT
MYGNMyriad Genetics Inc.5.46-1.44%$523.74Mvs QUIT
TKNOAlpha Teknova Inc.7.63-2.30%$479.95Mvs QUIT
NNNNAnbio Biotechnology Class A3.32-9.04%$145.72Mvs QUIT
ICCCImmuCell Corporation10.92-2.41%$99.28Mvs QUIT
IMDXInsight Molecular Diagnostics Inc.1.97+18.67%$80.88Mvs QUIT
VNRXVolitionRX Limited0.1621-1.58%$5.85Mvs QUIT
TRIBTrinity Biotech plc ADR6.24+13.76%$5.07Mvs QUIT

Related